Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dahmane Dahmani who wrote (396)	3/11/1997 1:48:00 AM
From: scaram(o)uche	of 6136

Ken and Dahmane: It's pretty much just wait and see now, no? The latest schedule of FDA advisory meetings is out and neither anti-virals nor Agouron is listed. Since AGPH is not saying that Viracept will not be approved before mid-April, I presume that this lends credibility to the "approval will be granted without an adivsory committee meeting" camp. I now regard that camp's view as a given, but that's my perspective. Get your own. :-) You have a company with no products and no product-related revenue with a market cap of better than a billion. You have a quiet period before the storm which has been characterized by worry and rumors. My own personal view is that it's a very good sign that the price has held up relatively well. 15% is nothing to veteran biotech investors, and I believe that any serious problems would have leaked and led to severe erosion in price. Everything, to me, looks good. As always, do your own homework. Cheers! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next